Skip to content
You are now leaving https://www.ionispharma.com to visit

Ionis Chairman and CEO Stanley T. Crooke, M.D., Ph.D. to receive Massry Prize for contributions to biomedical sciences

Prestigious Massry Foundation award recognizes Dr. Crooke’s pioneering work in RNA-targeted therapeutics CARLSBAD, Calif. , Oct. 23, 2019 /PRNewswire/ —  Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in RNA-targeted therapeutics, announced today that Ionis’ Chairman and Chief Executive